Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond.
Saved in:
| Title: | Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond. |
|---|---|
| Authors: | Qasim, Bushra1 (AUTHOR) bushraq157@gmail.com, Kumari, Hina2 (AUTHOR) hinakumari331@gmail.com, Kashif, Syeda Naveera3 (AUTHOR) kashifnaveera@gmail.com, Abbas, Syed Muhammad Iraj3 (AUTHOR) arj_rizvi@hotmail.com, Hani, Omme4 (AUTHOR) ommehani121@gmail.com, Salma, Omme5 (AUTHOR) ommesalma1610@gmail.com, Sauleh, Ahsan6 (AUTHOR) a.sauleh768@gmail.com, FNU Adnan7 (AUTHOR) Hussainiadnan40@gmail.com, Ali, Mashooque1 (AUTHOR) mariamkhowaja6020@gmail.com, Raheem, Abdul3 (AUTHOR) abdulraheem7712@gmail.com, Arifi, Muhammad Arif3 (AUTHOR) arifmuhammad9810@gmail.com, Muhammad, Faqeer8 (AUTHOR) faqeerm303@gmail.com, Maher, FNU1 (AUTHOR) dr.mashooquealikhowaja@gmail.com, Ameen, Taha Basit3 (AUTHOR) tahaameen05@gmail.com |
| Source: | Egyptian Liver Journal. 10/15/2025, Vol. 15 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20906218 |
|---|---|
| DOI: | 10.1186/s43066-025-00464-6 |
